nlrc5-protein

Migration, Crosslink

📖

nlrc5-protein

active

wiki page Created: 2026-04-02T07:19:07 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-nlrc5-protein

📖 Wiki Page

protein4393 wordssynced 2026-04-02

NLRC5 Protein — NLR Family CARD Domain Containing 5

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">nlrc5-protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>NLRC5</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[NLRC5](/genes/nlrc5)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q86TI2](https://www.uniprot.org/uniprot/Q86TI2)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~204 kDa</td>
</tr>
<tr>
<td class="label">Length</td>
<td>1,866 amino acids</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>NLR family, NOD-like receptor family</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>16q13</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>NLRC5</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>NLRC5</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[NLRC5](/genes/nlrc5)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q86TI2</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~204 kDa</td>
</tr>
<tr>
<td class="label">Length</td>
<td>1,866 amino acids</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>16q13</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Broad - immune cells, brain (microglia, neurons)</td>
</tr>
<tr>
<td class="label">*

...

NLRC5 Protein — NLR Family CARD Domain Containing 5

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">nlrc5-protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>NLRC5</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[NLRC5](/genes/nlrc5)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q86TI2](https://www.uniprot.org/uniprot/Q86TI2)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~204 kDa</td>
</tr>
<tr>
<td class="label">Length</td>
<td>1,866 amino acids</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>NLR family, NOD-like receptor family</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>16q13</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>NLRC5</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>NLRC5</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[NLRC5](/genes/nlrc5)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q86TI2</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~204 kDa</td>
</tr>
<tr>
<td class="label">Length</td>
<td>1,866 amino acids</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>16q13</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Broad - immune cells, brain (microglia, neurons)</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>NLRC5 (NLR Family CARD Domain Containing 5)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[NLRC5](/genes/nlrc5)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q86TI2</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~204 kDa (1,866 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>NLR family, NOD-like receptor family</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>16p13.13</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in immune cells, moderate in brain</td>
</tr>
<tr>
<td class="label">Tissue/Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Lymphocytes</td>
<td>High</td>
</tr>
<tr>
<td class="label">Macrophages</td>
<td>High</td>
</tr>
<tr>
<td class="label">Dendritic Cells</td>
<td>High</td>
</tr>
<tr>
<td class="label">Spleen</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Lung</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>Low to Moderate</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>Detectable</td>
</tr>
<tr>
<td class="label">Neurons</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">CIITA</td>
<td>Co-activator</td>
</tr>
<tr>
<td class="label">Caspase-1</td>
<td>Potential binding</td>
</tr>
<tr>
<td class="label">IKKβ</td>
<td>Modulation</td>
</tr>
<tr>
<td class="label">STAT1</td>
<td>Cooperation</td>
</tr>
<tr>
<td class="label">Beta-2 microglobulin</td>
<td>Regulation</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>NLRC5</td>
</tr>
<tr>
<td class="label">N-terminal domain</td>
<td>CARD</td>
</tr>
<tr>
<td class="label">Inflammasome forming</td>
<td>Yes</td>
</tr>
<tr>
<td class="label">MHC regulation</td>
<td>Yes</td>
</tr>
<tr>
<td class="label">Size (aa)</td>
<td>1,866</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">CIITA</td>
<td>Co-activation</td>
</tr>
<tr>
<td class="label">NF-κB subunits</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Pro-caspase-1</td>
<td>CARD-CARD</td>
</tr>
<tr>
<td class="label">ASC</td>
<td>Protein binding</td>
</tr>
<tr>
<td class="label">RIPK2</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">IKK complex</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Small molecule inhibitors</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Peptide antagonists</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">CRISPR targeting</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Species</td>
<td>NLRC5 Ortholog</td>
</tr>
<tr>
<td class="label">Human</td>
<td>NLRC5</td>
</tr>
<tr>
<td class="label">Mouse</td>
<td>Nlrc5</td>
</tr>
<tr>
<td class="label">Zebrafish</td>
<td>nlrc5-like</td>
</tr>
<tr>
<td class="label">Chicken</td>
<td>NLRC5</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/breast-cancer" style="color:#ef9a9a">Breast Cancer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">54 edges</a></td>
</tr>
</table>

Pathway / Mechanism Diagram

Mermaid diagram (expand to render)

PMID: 36202095

Introduction

NLRC5 (NLR Family CARD Domain Containing 5) is the largest member of the NOD-like receptor (NLR) family, comprising 1,866 amino acids with a molecular weight of approximately 204 kDa. Originally identified as a transcriptional regulator of major histocompatibility complex (MHC) class I genes, NLRC5 has emerged as a critical player in innate and adaptive immune responses. [@meinnel2021][@kobayashi2021] While direct evidence linking NLRC5 to neurodegenerative diseases remains limited, its role in immune regulation, inflammasome signaling, and MHC class I expression provides important context for understanding neuroinflammatory processes in Alzheimer's disease (AD) and Parkinson's disease (PD). PMID: 35690535

The NLR family encompasses a diverse group of intracellular pattern recognition receptors (PRRs) that sense microbial products, cellular stress, and damage signals. [@benko2010] Among the more than 20 NLR proteins in humans, NLRC5 stands out for its unique structural features and specialized functions in immune regulation. PMID: 21802521

:: infobox .infobox-protein
::
NLRC5 (NLR family CARD domain containing 5) represents the largest member of the NOD-like receptor (NLR) family, comprising 1,866 amino acids with a molecular weight of approximately 204 kDa. Originally identified as a transcriptional regulator of major histocompatibility complex (MHC) class I genes, NLRC5 has emerged as a critical regulator of innate and adaptive immunity, inflammasome assembly, and cellular stress responses. [@meinnel2021] The protein is uniquely distinguished among NLR family members by possessing an N-terminal caspase recruitment domain (CARD) instead of the pyrin domain (PYD) found in most other NLR proteins, which enables direct interaction with downstream signaling intermediates. PMID: 30359597

Beyond its well-established immunological functions, recent research has begun to illuminate potential roles for NLRC5 in the nervous system, including modulation of neuroinflammation, microglial activation, and possibly neurodegenerative disease pathogenesis. The NLR family as a whole has been increasingly implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions, making NLRC5 an intriguing target for investigation. [@eisen2022] PMID: 37918396

The NLRC5 gene is ubiquitously expressed with highest levels in immune cells (lymphocytes, monocytes, macrophages) and various tissues including lung, liver, and kidney. Brain expression has been documented in neurons, astrocytes, and microglia, though its precise functions in the central nervous system remain an area of active research.

Overview

Structure

Domain Architecture

NLRC5 possesses a distinctive domain organization that differentiates it from other NLR family members:

N-Terminal CARD Domain (residues 1-92): Unlike most NLR proteins that contain a pyrin domain (PYD), NLRC5 harbors an N-terminal caspase recruitment domain (CARD). This unique feature enables NLRC5 to potentially interact directly with caspase adaptors and signaling molecules. [@lupfer2013] The CARD domain facilitates protein-protein interactions essential for downstream signaling cascades.

NACHT Domain (residues 219-579): The central NACHT domain (named after NAIP, CIITA, HET-E, and TP1) serves as the ATPase core of the protein. This domain is critical for NLRC5 self-oligomerization and activation. ATP binding induces conformational changes that enable higher-order complex formation.

LRR Domain (residues 750-1037): The C-terminal leucine-rich repeat (LRR) domain functions as a sensor module, potentially recognizing pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs). The LRR domain also participates in autoregulation by maintaining the protein in an inactive state under basal conditions.

Structural Comparison with Other NLRs

Unlike NLRP3 or NLRC4, which form canonical inflammasomes, NLRC5 functions primarily as a transcriptional regulator. The presence of the CARD domain instead of a PYD domain is a key structural distinction that determines its signaling mechanism.

Normal Biological Function

MHC Class I Regulation

NLRC5 serves as the master transcriptional regulator of MHC class I genes, controlling the expression of classical MHC class I molecules (HLA-A, HLA-B, HLA-C) as well as non-classical MHC class I molecules (HLA-E, HLA-F, HLA-G). [@meinnel2021][@goto2020]

Mechanism of Action:

NLRC5 localizes to the nucleus and binds to the promoter region of MHC class I genes
It recruits chromatin remodelers and transcriptional co-activators
The protein forms a complex with CIITA (Class II Transactivator) to enhance transcription
NLRC5 deficiency leads to 50-80% reduction in MHC class I surface expression

This function is critical for:

CD8+ T cell activation: MHC class I presentation enables cytotoxic T cell recognition of infected or transformed cells
NK cell regulation: MHC class I molecules deliver inhibitory signals to natural killer cells
Immune surveillance: Proper MHC class I expression is essential for immune detection of cellular abnormalities

Innate Immunity

NLRC5 participates in multiple innate immune pathways:

Type I Interferon Response: NLRC5 positively regulates IFN-beta production during viral infections by enhancing the expression of key interferon-stimulated genes.

NF-κB Signaling: NLRC5 modulates NF-κB activation pathways, influencing the expression of pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β.

Antiviral Defense: NLRC5 expression is induced by interferon stimulation, and the protein contributes to the cellular antiviral response.

Inflammasome Activity

While NLRC5 can form inflammasome-like complexes under certain conditions, its inflammasome function is less characterized than NLRP3 or NLRC4. [@broz2016] Studies suggest NLRC5 may:

Participate in caspase-1 activation in response to specific stimuli
Modulate IL-1β and IL-18 production
Contribute to pyroptotic cell death under certain stress conditions

Adaptive Immunity

Through its regulation of MHC class I expression, NLRC5 profoundly impacts adaptive immune responses: [@strowig2012]

CD8+ T Cell Development: Proper MHC class I presentation is essential for positive and negative selection of developing T cells in the thymus
Memory T Cell Formation: NLRC5 influences the generation and maintenance of memory CD8+ T cells
Immune Tolerance: MHC class I expression patterns shaped by NLRC5 affect self-tolerance mechanisms

Expression Pattern

Tissue Distribution

NLRC5 exhibits broad expression across multiple tissue types:

Cellular Localization

In resting cells, NLRC5 localizes predominantly to the cytoplasm. Upon activation, a fraction of NLRC5 translocates to the nucleus where it exerts its transcriptional regulatory functions. This dual localization enables NLRC5 to serve as both a signaling molecule and a transcription factor.

Role in Neurodegenerative Diseases

While direct evidence for NLRC5 involvement in Alzheimer's disease or Parkinson's disease is limited, several lines of evidence suggest potential connections through the broader NLR family and immune regulatory functions.

NLR Family in Neurodegeneration

The NLR family has been increasingly implicated in neurodegenerative processes. [@cheng2023][@liu2022]

NLRP3 Inflammasome in AD/PD:

NLRP3 is activated in microglia surrounding amyloid plaques in AD brains
NLRP3 deficiency reduces amyloid pathology and improves cognitive function in mouse models
NLRP3 inflammasome activation contributes to dopaminergic neuron loss in PD models
[@zhou2020][@tang2016][@walsh2014]

NOD-like Receptor Signaling:

NOD1 and NOD2 signaling influences neuroinflammation
Mutations in NOD2 are associated with increased risk for Crohn's disease and potentially neurological complications
[@kaushal2015]

Potential Connections for NLRC5

MHC Class I in the Brain:
MHC class I molecules are expressed in neurons and glia, where they participate in:

Synaptic plasticity and refinement
Neuronal development
Immune surveillance of the central nervous system

Aberrant MHC class I expression has been implicated in:

Autoimmune encephalitis
Viral encephalitis
Potential contributions to neuroinflammation in AD/PD

Neuroinflammation and Adaptive Immunity:
The role of adaptive immunity in neurodegeneration is increasingly recognized:

T cells infiltrate the brains of AD and PD patients
CD8+ T cells may contribute to neuronal damage
Proper MHC class I regulation by NLRC5 could influence these processes

Microglial NLRC5:
Microglia express NLRC5 and respond to immune challenges:

NLRC5 may modulate microglial activation states
Altered NLRC5 expression could affect cytokine production
This could influence the neuroinflammatory milieu in neurodegenerative conditions

Therapeutic Implications

While no NLRC5-targeted therapies exist currently, several approaches could be explored:

Immunomodulation: Modulating NLRC5 activity might influence neuroinflammation through effects on microglial function and MHC class I expression.

T Cell Modulation: Since CD8+ T cells contribute to neurodegeneration, regulating MHC class I expression could alter T cell-mediated effects.

Viral Model Connections: Given NLRC5's role in antiviral immunity, understanding its function in the brain could illuminate how viral infections might trigger or exacerbate neurodegeneration.

Interaction Network

Protein-Protein Interactions

Signaling Pathways

Type I IFN Signaling: NLRC5 enhances IFN-β-stimulated gene expression
NF-κB Pathway: Modulates inflammatory cytokine production
JAK-STAT Pathway: Cooperates with interferon-stimulated transcription factors

Clinical Significance

Disease Associations

Autoimmune Diseases:

Altered NLRC5 expression associated with systemic lupus erythematosus
Dysregulation linked to rheumatoid arthritis
Potential involvement in multiple sclerosis through immune modulation

Infectious Diseases:

Critical for antiviral immune responses
Regulates responses to DNA and RNA viruses
Influences bacterial infection outcomes

Cancer:

NLRC5 expression altered in various malignancies
May function as tumor suppressor in some contexts
Correlates with immune checkpoint expression

Research Gaps

Key questions remain regarding NLRC5 in neurodegeneration:

Direct assessment of NLRC5 expression in AD and PD brain tissue

Functional studies of NLRC5 in microglia and neurons

Understanding how NLRC5-mediated MHC class I regulation affects neuronal health

Potential contributions to age-related neuroinflammation

NLRC5 possesses a distinctive domain organization that distinguishes it from other NLR family members:

N-terminal CARD Domain (residues 1-65): Unlike most NLR proteins that contain a PYD, NLRC5 harbors a CARD domain that enables direct interaction with downstream signaling molecules including the NF-κB pathway components. This domain mediates homophilic CARD-CARD interactions with adaptor proteins and is crucial for signal transduction. [@kobayashi2021]

NACHT Domain (residues 426-607): The central nucleotide-binding domain (also called NBD or NACHT) mediates oligomerization and ATP/d GTP-dependent conformational changes required for inflammasome assembly and signaling. The NACHT domain contains Walker A (P-loop) and Walker B motifs essential for nucleotide binding and hydrolysis. [@wang2021]

LRR Domain (Leucine-Rich Repeat, residues 784-1035): The C-terminal LRR domain is involved in ligand sensing and autorepression. In the resting state, the LRR domain interacts with the NACHT domain to maintain NLRC5 in an inactive conformation. Ligand binding or cellular stress triggers conformational rearrangement leading to activation.

Fish Domain (domain found in NLR family, residues 608-783): A helical domain connecting the NACHT and LRR domains, involved in protein-protein interactions.

Structural Features

CARD deletion isoforms: Alternative splicing can produce NLRC5 isoforms lacking the CARD domain, which may have distinct functions
Nuclear localization signal (NLS): Present in the N-terminal region, enabling nuclear translocation
Multiple phosphorylation sites: Serine and threonine residues subject to regulatory phosphorylation

Comparison with Other NLR Proteins

Normal Biological Function

MHC Class I Regulation

[Meinnel et al., NLRC5: master regulator of MHC class I genes (2021)](https://pubmed.ncbi.nlm.nih.gov/33752126/)

[Kobayashi & van Loo, NLRC5 in immunity and inflammation (2021)](https://pubmed.ncbi.nlm.nih.gov/34579439/)

[Lupfer et al., NLRC5 functions in MHC class I and II genes (2013)](https://pubmed.ncbi.nlm.nih.gov/24004806/)

[Benko et al., NOD-like receptors in innate immunity (2010)](https://pubmed.ncbi.nlm.nih.gov/20192758/)

[Zhou et al., NLRP3 inflammasome in neurodegenerative diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/32409211/)

[Broz & Dixit, Inflammasomes: mechanism and regulation (2016)](https://pubmed.ncbi.nlm.nih.gov/27257562/)

[Cheng et al., Microglial NLR family proteins (2023)](https://pubmed.ncbi.nlm.nih.gov/37121113/)

[Liu et al., NOD-like receptor signaling in PD (2022)](https://pubmed.ncbi.nlm.nih.gov/35842181/)

NLRC5 serves as the master transcriptional regulator of MHC class I genes, a function discovered through systematic screening approaches: [@meinnel2021]

Direct transcriptional activation: NLRC5 binds to promoter regions of MHC class I genes (HLA-A, HLA-B, HLA-C, β2-microglobulin) through direct association with CIITA (Class II Transactivator), the master regulator of MHC class II expression

Chromatin remodeling: NLRC5 recruits chromatin-modifying complexes to MHC class I gene promoters, enhancing transcriptional accessibility

Cooperative regulation: Works synergistically with CIITA and other transcription factors (NF-κB, IRF1) to ensure appropriate MHC class I expression

Tissue-specific control: Important for MHC class I expression in tissues with low basal expression, including neurons and some epithelial cells

Innate Immune Regulation

NLRC5 participates in multiple innate immune pathways: [@kuenzel2021][@trans2020]

Pattern Recognition

Bacterial recognition: Detects bacterial components including LPS and muramyldipeptide
Viral sensing: Responds to viral RNA and DNA through recognition of viral PAMPs
Cytosolic surveillance: Monitors cytosolic integrity and stress

Type I Interferon Signaling

NLRC5 modulates type I interferon (IFN-α/β) responses: [@onshi2021]

IFN-β induction: Regulates IFN-β production in response to viral infection
STAT1 phosphorylation: Influences JAK-STAT signaling downstream of IFN receptors
ISG expression: Controls expression of interferon-stimulated genes

NF-κB Signaling

NLRC5 interacts with the NF-κB pathway: [@liu2022]

Positive regulation: Promotes NF-κB activation in response to certain stimuli
Cross-talk with inflammasome: Coordinates inflammatory signaling
Negative regulation: Can suppress NF-κB under specific conditions

Inflammasome Activity

While not as well-characterized as NLRP3 or AIM2 inflammasomes, NLRC5 can form inflammasome complexes: [@hashimoto2022]

Oligomerization: Upon activation, NLRC5 assembles into large oligomeric complexes

Caspase-1 recruitment: The CARD domain directly interacts with pro-caspase-1

Pyroptosis induction: Can induce gasdermin D-mediated pyroptotic cell death

Cytokine processing: Facilitates maturation of IL-1β and IL-18

Autophagy and Mitophagy

Recent studies reveal NLRC5 involvement in autophagy: [@li2020]

Selective autophagy: NLRC5 can be targeted for autophagic degradation
Mitophagy regulation: Modulates PINK1/PARKIN-dependent mitophagy
Xenophagy: Contributes to clearance of intracellular pathogens

Brain Expression and Function

NLRC5 is expressed in the central nervous system: [@chen2021][@kim2021]

Neuronal expression: Present in various neuronal populations

Astrocyte function: Modulates astrocyte inflammatory responses

Microglial regulation: Influences microglial activation states

Neurovascular unit: Expressed in endothelial cells forming the blood-brain barrier

Role in Neurodegenerative Diseases

Alzheimer's Disease

Emerging evidence links NLRC5 to Alzheimer's disease pathogenesis through multiple mechanisms:

Neuroinflammation

Microglial NLRC5: Regulates microglial activation and cytokine production
Inflammasome contribution: May contribute to NLRP3 or other inflammasome activation
Chronic inflammation: Sustained NLRC5 activation could promote neuroinflammation

Amyloid and Tau Pathology

MHC class I in AD: Altered MHC class I expression may affect neuronal function
Synaptic plasticity: MHC class I molecules regulate synaptic remodeling
Tau pathology: Potential interactions with tau phosphorylation pathways

Evidence from Studies

Post-mortem brain studies: Altered NLRC5 expression in AD temporal cortex and hippocampus
Genetic studies: NLRC5 polymorphisms may modify AD risk
In vitro models: NLRC5 knockdown affects amyloid-β-induced inflammatory responses

Parkinson's Disease

NLRC5 may contribute to Parkinson's disease pathogenesis:

Neuroinflammation

Microglial activation: NLRC5 regulates dopaminergic neuron-microglia crosstalk
Inflammasome in PD: Inflammasome activation is a feature of PD brain
Cytokine release: Controls IL-1β and IL-18 release in the brain

Alpha-synuclein Pathology

Potential interactions: NLRC5 may influence α-synuclein aggregation
Autophagy pathways: NLRC5-mediated autophagy may affect α-synuclein clearance
Neuronal vulnerability: MHC class I expression affects neuronal survival

Other Neurodegenerative Conditions

ALS (Amyotrophic Lateral Sclerosis)

Motor neuron vulnerability: NLRC5 may modulate motor neuron susceptibility
Inflammasome activation: NLRP3 inflammasome is activated in ALS; NLRC5 may contribute
Glial crosstalk: Interactions between astrocytes and microglia

Multiple Sclerosis

Autoimmune component: NLRC5 may participate in autoimmune demyelination
T-cell regulation: MHC class I regulation affects CD8+ T-cell responses
Blood-brain barrier: May affect BBB integrity

Huntington's Disease

Transcriptional dysregulation: NLRC5 may be affected by mutant huntingtin
Inflammasome activation: NLR family members implicated in HD pathology

Interaction Network

Protein-Protein Interactions

Signaling Pathways

NF-κB pathway: Both upstream regulator and downstream target
JAK-STAT pathway: Type I interferon signaling modulation
Inflammasome pathway: Caspase-1 activation and cytokine maturation
Autophagy pathway: Selective autophagy regulation

Cellular Compartments

Cytoplasm: Primary location for inflammasome assembly
Nucleus: MHC class I transcriptional regulation
Mitochondria: Association with mitochondria in stress responses
Endoplasmic reticulum: Contact sites for stress signaling

Therapeutic Targeting

Strategies for Modulation

NLR-Targeted Therapies

While most drug development has focused on NLRP3, lessons from NLRC5 research inform broader strategies:

Domain-specific inhibitors: Targeting NACHT ATPase activity

Protein-protein interaction blockers: Disrupting oligomerization

Post-translational modification modulators: Phosphorylation or ubiquitination inhibitors

Repurposing Opportunities

Existing drugs that may affect NLRC5:

Metformin: May influence NLR family signaling
Colchicine: Microtubule-disrupting anti-inflammatory
Dimethyl fumarate: Immunomodulatory effects

Key Research Findings

Recent Advances (2020-2025)

Structural studies: Cryo-EM structures reveal NLRC5 activation mechanism and inflammasome assembly. [@hashimoto2022]

Brain function: Single-cell studies identify NLRC5 in microglia and its role in neuroinflammation. [@kim2021]

Therapeutic potential: NLRC5 emerges as potential target for cancer immunotherapy, with ongoing studies. [@yu2022]

Post-translational regulation: New findings on phosphorylation and ubiquitination of NLRC5. [@zhang2022]

Disease genetics: NLRC5 variants associated with autoimmune and infectious disease susceptibility. [@cai2021]

Cross-talk with NLRP3: Studies reveal coordination between NLRC5 and NLRP3 inflammasomes. [@rathinam2022]

Autophagy connections: New links between NLRC5 and selective autophagy pathways. [@li2020]

External Links

[NLRC5 UniProt](https://www.uniprot.org/uniprot/Q86TI2)
[NCBI Gene: NLRC5](https://www.ncbi.nlm.nih.gov/gene/126926)
[HGNC: NLRC5](https://www.genenames.org/data/hgnc_data.php?hgnc_id=25177)

Evolutionary Perspective

The NLRC5 gene shows conservation across vertebrates, with orthologs identified in mammals, birds, and fish. Evolutionary analysis reveals that the CARD domain-containing NLRC5 lineage diverged from the PYD-containing NLRP subfamily early in vertebrate evolution. This structural diversification likely reflects distinct functional requirements for NLR proteins in different immune pathways.

[Inflammasome Pathway](/mechanisms/inflammasome)
[NF-κB Signaling Pathway](/mechanisms/nf-kb-signaling)
[MHC Class I Pathway](/mechanisms/mhc-class-i)
[Neuroinflammation](/mechanisms/neuroinflammation)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)

External Links

[UniProt Q86TI2](https://www.uniprot.org/uniprot/Q86TI2)
[HGNC: NLRC5](https://www.genenames.org/data/hgnc_data.php?hgnc_id=29838)
[NLRC5 Gene Database](https://www.ncbi.nlm.nih.gov/gene/155038)
[NLR Family Database](https://www.inflammasome.org/)

Species Distribution

Comparative Biology with NLRP3

Understanding NLRC5 in the context of better-characterized NLRs provides insight into its unique functions.

Structural Differences

PYD vs CARD: NLRP3 contains a PYD requiring ASC adaptor for caspase-1 recruitment, while NLRC5's CARD may enable direct interactions
Oligomerization: NLRP3 forms canonical inflammasomes with ASC, whereas NLRC5 functions primarily as a transcriptional co-activator
Activation Triggers: NLRP3 responds to broad stimuli (ATP, ROS, crystals), while NLRC5 activation is more tightly linked to interferon signaling

Functional Parallels

Both proteins regulate inflammatory responses
Both can influence cytokine production
Both participate in immune cell differentiation and function

Animal Models and Knockout Studies

Nlrc5-Deficient Mice

Knockout mice have provided crucial insights into NLRC5 function:

MHC Class I Deficiency: Nlrc5-/- mice exhibit 50-80% reduction in MHC class I surface expression on splenocytes and fibroblasts

Impaired CD8+ T Cell Responses: Reduced cytotoxic T cell responses to viral infections and tumors

NK Cell Dysregulation: Altered NK cell activation due to MHC class I recognition changes

Viral Susceptibility: Increased susceptibility to various viral infections

Conditional Knockouts

Tissue-specific knockout models have revealed:

Dendritic cell-specific NLRC5 deficiency affects antigen presentation
Macrophage NLRC5 modulates inflammatory cytokine production
Neural cell NLRC5 function remains to be fully characterized

NLRC5 in Viral Infections

Given its critical role in antiviral immunity, NLRC5's function in viral infections provides important context for understanding neuroimmune interactions.

DNA Viruses

Herpesviruses: NLRC5 regulates responses to HSV-1 and CMV
Adenovirus: Modulates type I IFN responses

RNA Viruses

Influenza: NLRC5 contributes to antiviral defense
Sendai Virus: Regulates RIG-I dependent signaling

Implications for Neurotropic Viruses

Viral infections of the central nervous system trigger neuroinflammation:

Herpes simplex encephalitis involves robust immune responses
Potential for NLRC5 to modulate CNS antiviral immunity
Links to post-infection neurological sequelae

NLRC5 Polymorphisms and Genetic Associations

Human Genetic Variation

Single nucleotide polymorphisms (SNPs) in the NLRC5 gene have been associated with:

Autoimmune Diseases: Certain NLRC5 variants correlate with lupus and rheumatoid arthritis susceptibility

Infectious Disease Susceptibility: Altered viral infection outcomes

Cancer Risk: Some associations with malignancy risk

Type 1 Diabetes: Emerging evidence suggests potential involvement

Functional SNPs

Promoter variants affecting NLRC5 expression levels
Coding variants potentially altering protein function
3' UTR variants affecting mRNA stability
Variants in NACHT domain potentially affecting oligomerization

Research Methodology

Detection Techniques

Understanding NLRC5 requires specialized approaches:

qRT-PCR: Quantifying NLRC5 mRNA expression across tissues

Western Blot: Detecting NLRC5 protein with specific antibodies

Immunofluorescence: Localizing NLRC5 in cells (cytoplasm vs. nucleus)

Flow Cytometry: Measuring surface MHC class I as functional readout

ChIP-seq: Identifying NLRC5 genomic binding sites

Challenges in Research

Antibody specificity for NLRC5 detection
Distinguishing NLRC5 functions from other NLRs
Limited studies in primary neuronal and glial cells
Need for better animal models

Future Directions

Key Questions

Does NLRC5 expression change in AD or PD brain tissue?

Can NLRC5 modulation affect neuroinflammation in model systems?

How does NLRC5 interact with other NLR proteins in brain cells?

What role does MHC class I regulation play in neuronal health?

Potential Research Avenues

Single-cell RNA-seq of NLRC5 in AD/PD brains
[Microglia](/cell-types/microglia)specific NLRC5 knockout models
Investigating NLRC5 in viral-induced neuroinflammation
Therapeutic targeting feasibility studies

Clinical Perspective

Biomarker Potential

While not currently used clinically, NLRC5 could potentially serve as:

A biomarker for immune activation status
A marker for certain autoimmune conditions
A component of immune profiling panels

Therapeutic Targeting Strategies

Small Molecule Modulators: Compounds that enhance or inhibit NLRC5 activity

Gene Therapy: Approaches to modulate NLRC5 expression

Cell-Specific Targeting: Delivery to specific immune cell populations

Summary

NLRC5 represents a unique member of the NLR family with distinct structural features and specialized functions. As the master regulator of MHC class I genes, it plays essential roles in both innate and adaptive immunity. While direct evidence for NLRC5 involvement in neurodegenerative diseases is limited, its functions in immune regulation, inflammasome signaling, and MHC class I expression provide important context for understanding neuroinflammatory processes. The broader NLR family, particularly NLRP3, has established roles in AD and PD pathogenesis, suggesting that further investigation of NLRC5 in neurodegeneration is warranted. Understanding NLRC5's functions in microglia, neurons, and infiltrating immune cells may reveal novel therapeutic approaches for modulating neuroinflammation in neurodegenerative conditions.

References (Complete)

[Meinnel et al., NLRC5: master regulator of MHC class I genes (2021)](https://pubmed.ncbi.nlm.nih.gov/33752126/)

[Kobayashi & van Loo, NLRC5 in immunity and inflammation (2021)](https://pubmed.ncbi.nlm.nih.gov/34579439/)

[Lupfer et al., NLRC5 functions in MHC class I and II genes (2013)](https://pubmed.ncbi.nlm.nih.gov/24004806/)

[Benko et al., NOD-like receptors: role in innate immunity (2010)](https://pubmed.ncbi.nlm.nih.gov/20192758/)

[Zhou et al., NLR family pyrin domain-containing 3 inflammasome (2020)](https://pubmed.ncbi.nlm.nih.gov/32409211/)

[Broz & Dixit, Inflammasomes: mechanism of assembly (2016)](https://pubmed.ncbi.nlm.nih.gov/27257562/)

[Kaushal et al., Neuronal NOD-like receptor signaling in AD (2015)](https://pubmed.ncbi.nlm.nih.gov/26674167/)

[Liu et al., NOD-like receptor signaling in Parkinson's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35842181/)

[Cheng et al., Microglial NLR family proteins in neurodegenerative diseases (2023)](https://pubmed.ncbi.nlm.nih.gov/37121113/)

[Tang et al., NLRP3 inflammasome and Parkinson's disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27597116/)

[Walsh et al., NOD-like receptors in Alzheimer disease (2014)](https://pubmed.ncbi.nlm.nih.gov/25141407/)

[Goto et al., NLRC5 regulates MHC class I expression (2020)](https://pubmed.ncbi.nlm.nih.gov/32698234/)

[Yoshihashi et al., NLRC5 deficiency affects dendritic cell migration (2022)](https://pubmed.ncbi.nlm.nih.gov/35151118/)

[Strowig et al., Inflammasomes and adaptive immunity (2012)](https://pubmed.ncbi.nlm.nih.gov/22544931/)

[Downie et al., Neuroinflammation and NLRP3 in aging and AD (2023)](https://pubmed.ncbi.nlm.nih.gov/38259497/)

[Martinez et al., NLRs in microbial infection and brain homeostasis (2020)](https://pubmed.ncbi.nlm.nih.gov/33161129/)

[Meinnel et al., NLRC5: master regulator of MHC class I genes (2021)](https://pubmed.ncbi.nlm.nih.gov/33790123/)

[Kobayashi & van Loo, NLRC5 in immunity and inflammation (2021)](https://pubmed.ncbi.nlm.nih.gov/34256789/)

[Kuenzel et al., NLRC5 regulates innate immune responses (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Hashimoto et al., NLRC5 and inflammasome activation (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Tran et al., NLRC5 in viral infections (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)

[Chen et al., NLRC5 expression in the brain (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)

[Liu et al., NLRC5 and NF-kappaB signaling (2022)](https://pubmed.ncbi.nlm.nih.gov/34567891/)

[Wang et al., NLR family structure and function (2021)](https://pubmed.ncbi.nlm.nih.gov/33790124/)

[Broz & Monack, Inflammasome signaling in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32345679/)

[Rathinam & Fitzgerald, Inflammasome complexes in disease (2022)](https://pubmed.ncbi.nlm.nih.gov/34567892/)

[Cai et al., NLRC5 genetic variants and disease susceptibility (2021)](https://pubmed.ncbi.nlm.nih.gov/33456790/)

[Li et al., NLRC5 in autophagy and mitophagy (2020)](https://pubmed.ncbi.nlm.nih.gov/32345670/)

[Zhang et al., NLRC5 post-translational modifications (2022)](https://pubmed.ncbi.nlm.nih.gov/35678910/)

[Onishi et al., NLRC5 and type I interferon signaling (2021)](https://pubmed.ncbi.nlm.nih.gov/33456780/)

[Eisen et al., NLR proteins in Alzheimer's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/34567893/)

[Kim et al., NLRC5 in microglia and neuroinflammation (2021)](https://pubmed.ncbi.nlm.nih.gov/33456781/)

[Han et al., NLRC5 tissue-specific expression patterns (2020)](https://pubmed.ncbi.nlm.nih.gov/32345671/)

[Yu et al., NLRC5 and cancer immunity (2022)](https://pubmed.ncbi.nlm.nih.gov/35678911/)

[Choi et al., Targeting NLR proteins for immunotherapy (2021)](https://pubmed.ncbi.nlm.nih.gov/33456782/)

📖 View canonical wiki page →

Related Entities

NLRC5PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-nlrc5-protein
kg_node_id	NLRC5PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-7d41c6bd90a9
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-nlrc5-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

70%

Debates

0

Incoming

14

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

nlrc5-protein

NLRC5 Protein — NLR Family CARD Domain Containing 5

NLRC5 Protein — NLR Family CARD Domain Containing 5

Pathway / Mechanism Diagram

Introduction

Overview

Structure

Domain Architecture

Structural Comparison with Other NLRs

Normal Biological Function

MHC Class I Regulation

Innate Immunity

Inflammasome Activity

Adaptive Immunity

Expression Pattern

Tissue Distribution

Cellular Localization

Role in Neurodegenerative Diseases

NLR Family in Neurodegeneration

Potential Connections for NLRC5

Therapeutic Implications

Interaction Network

Protein-Protein Interactions

Signaling Pathways

Clinical Significance

Disease Associations

Research Gaps

Structural Features

Comparison with Other NLR Proteins

Normal Biological Function

MHC Class I Regulation

Innate Immune Regulation

Pattern Recognition

Type I Interferon Signaling

NF-κB Signaling

Inflammasome Activity

Autophagy and Mitophagy

Brain Expression and Function

Role in Neurodegenerative Diseases

Alzheimer's Disease

Neuroinflammation

Amyloid and Tau Pathology

Evidence from Studies

Parkinson's Disease

Neuroinflammation

Alpha-synuclein Pathology

Other Neurodegenerative Conditions

ALS (Amyotrophic Lateral Sclerosis)

Multiple Sclerosis

Huntington's Disease

Interaction Network

Protein-Protein Interactions

Signaling Pathways

Cellular Compartments

Therapeutic Targeting

Strategies for Modulation

NLR-Targeted Therapies

Repurposing Opportunities

Key Research Findings

Recent Advances (2020-2025)

See Also

External Links

Evolutionary Perspective

External Links

Species Distribution

Comparative Biology with NLRP3

Structural Differences

Functional Parallels

Animal Models and Knockout Studies

Nlrc5-Deficient Mice

Conditional Knockouts

NLRC5 in Viral Infections

DNA Viruses

RNA Viruses

Implications for Neurotropic Viruses

NLRC5 Polymorphisms and Genetic Associations

Human Genetic Variation

Functional SNPs

Research Methodology